Operation of the Institute

Címlap >> Content >> Operation of the Institute

The National Institute of Oncology is the property of the Ministry of Health (1051 Budapest, Arany János u. 6-8.), and its main function is to provide complex oncotherapy for out- and inpatients from any region of the country.

The Institute's budget is provided by:

  • National Health Insurance Fund (NEAK) for operating costs
  • Ministry of Health for modernization and other investments

The Institute is supervised by the Ministry of Health

The Institute's funtions:

  • Active inpatient care
  • Central diagnostic and therapeutic care
  • Outpatient care
  • Research and development
  • Post-graduate training
  • Central specialist services
  • National Cancer Registry
  • International cooperations

The main task of the management is to ensure that the medical-, the nursing- and the quality-controlling systems work perfectly. The multidisciplinary approach of cancer diseases is very important, because in many types of cancer surgical-, radio- and chemotherapy are all needed. Sometimes the treatments can substitute each other, or can be optimized by individual prognostic factors, or by considering new therapeutic procedures. To achieve these things, a collective decision-making mechanism is needed, that can avoid under- or overtreatment, and bad combinations of therapies. This system is maintained by discussing the following subjects at work meetings and training conferences, involving all the representatives of the different disciplines:

Regular institute management meetings:

  • Presentation of some of the cancer patients before treatment (central consultant committees);
  • Application of standard protocols in typical cases and in special circumstances.

Regular training conferences:

  • Efficiency of the applied treatments (results of trials, 5-year survival rates);
  • New therapeutic techniques and protocols;
  • Methods for the assessment of individual clinical courses according to tumour localizations;
  • New tumour classifications;
  • New entities;
  • Cancer analgesia;
  • Acknowledged research results to be integrated in clinical practice.

Pathological diagnostics, molecular biological-prognosis of tumours, and genetic screenings are all available in the Institute. The National Cancer Registry also operates within the Institute, that collects cancer morbidity and mortality data from all over the country.

The Institute has its own controlling system. The quality management system is used in:

  • Active inpatient care
  • Central diagnostic and therapeutic care
  • Outpatient care
  • Research and developement
  • Post-graduate training
  • Central specialist service

and in all other supporting and controlling activities

vice and in all other supporting and controlling activities